The main focus of BNB lab is to develop new micro/nanodevices that can sense and characterize biological entities, processes, and interactions that can be used for diagnostics and to measure the therapeutic effect. Such devices can have immediate and far-reaching impacts in medicine.


Point-of-care disease diagnostics:

We are developing nanofabricated and microfluidic devices to sense and characterize important biomarkers for various diseases including cancer and HIV.

Structural biomaterials for bone-implant systems:

We are also developing novel bioinks for 3-D printed structural biomaterials to understand the role of biomaterial surface morphology and chemistry in cellular attachment, surface bioactivity, and gene expressions for rapid fracture healing.